{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:47:16Z","timestamp":1794023236317,"version":"4.8.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04452-z","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T12:47:20Z","timestamp":1780836440000},"page":"5504-5513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Predicting time to local failure after gamma knife radiosurgery for melanoma brain metastases using survival machine learning"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-0881","authenticated-orcid":false,"given":"Jheremy S.","family":"Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Bouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Niranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Dade.","family":"Lunsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-6644","authenticated-orcid":false,"given":"Constantinos G.","family":"Hadjipanayis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,7]]},"reference":[{"issue":"1","key":"4452_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/2016.9.JNS161011","volume":"128","author":"H Kano","year":"2018","unstructured":"Kano H, Morales-Restrepo A, Iyer A, Weiner GM, Mousavi SH, Kirkwood JM, et al. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery. J Neurosurg. 2018;128(1):14\u201322. https:\/\/doi.org\/10.3171\/2016.9.JNS161011.","journal-title":"J Neurosurg"},{"key":"4452_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000493057","volume":"34","author":"A Niranjan","year":"2019","unstructured":"Niranjan A, Lunsford LD, Ahluwalia MS. Targeted therapies for brain metastases. Prog Neurol Surg. 2019;34:125\u201337. https:\/\/doi.org\/10.1159\/000493057.","journal-title":"Prog Neurol Surg"},{"issue":"5","key":"4452_CR3","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3171\/2020.3.JNS193369","volume":"134","author":"GN Bowden","year":"2021","unstructured":"Bowden GN, Kim JO, Faramand A, Fallon K, Flickinger J, Lunsford LD. Clinical dose profile of Gamma Knife stereotactic radiosurgery for extensive brain metastases. J Neurosurg. 2021;134(5):1430\u20134. https:\/\/doi.org\/10.3171\/2020.3.JNS193369.","journal-title":"J Neurosurg"},{"issue":"7","key":"4452_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26553","volume":"14","author":"Z Wei","year":"2022","unstructured":"Wei Z, Waite K, Deng H, Najjar Y, Niranjan A, Lunsford LD. Aggressive stereotactic radiosurgery coupled with immune and targeted therapy for recurrent melanoma brain metastases: a case report and literature review. Cureus. 2022;14(7):e26553. https:\/\/doi.org\/10.7759\/cureus.26553.","journal-title":"Cureus"},{"issue":"6","key":"4452_CR5","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1227\/neu.0000000000002127","volume":"91","author":"EJ Lehrer","year":"2022","unstructured":"Lehrer EJ, Gurewitz J, Bernstein K, Kondziolka D, Fakhoury KR, Rusthoven CG, et al. Concurrent administration of immune checkpoint inhibitors and stereotactic radiosurgery is well-tolerated in patients with melanoma brain metastases: an international multicenter study of 203 patients. Neurosurgery. 2022;91(6):872\u201382. https:\/\/doi.org\/10.1227\/neu.0000000000002127.","journal-title":"Neurosurgery"},{"issue":"5","key":"4452_CR6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3171\/2022.7.JNS22752","volume":"138","author":"EJ Lehrer","year":"2023","unstructured":"Lehrer EJ, Ahluwalia MS, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, et al. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients. J Neurosurg. 2023;138(5):1178\u201387. https:\/\/doi.org\/10.3171\/2022.7.JNS22752.","journal-title":"J Neurosurg"},{"issue":"4","key":"4452_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.ijrobp.2023.01.017","volume":"116","author":"EJ Lehrer","year":"2023","unstructured":"Lehrer EJ, Kowalchuk RO, Gurewitz J, Bernstein K, Kondziolka D, Niranjan A, et al. Concurrent administration of immune checkpoint inhibitors and single fraction stereotactic radiosurgery in patients with non-small cell lung cancer, melanoma, and renal cell carcinoma brain metastases. Int J Radiat Oncol Biol Phys. 2023;116(4):858\u201368. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.01.017.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4452_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11060-020-03427-6","volume":"151","author":"EJ Lehrer","year":"2021","unstructured":"Lehrer EJ, McGee HM, Sheehan JP, Trifiletti DM. Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases. J Neurooncol. 2021;151(1):75\u201384. https:\/\/doi.org\/10.1007\/s11060-020-03427-6.","journal-title":"J Neurooncol"},{"issue":"1","key":"4452_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.08.017","volume":"6","author":"RL Travis","year":"2021","unstructured":"Travis RL, Marcrom SR, Brown MH, Patel MP, Markert JM, Riley KO, et al. Control and toxicity in melanoma versus other brain metastases in response to combined radiosurgery and PD-(L)1 immune checkpoint inhibition. Adv Radiat Oncol. 2021;6(1):100561. https:\/\/doi.org\/10.1016\/j.adro.2020.08.017.","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"4452_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3390\/curroncol28010045","volume":"28","author":"WJ Phillips","year":"2021","unstructured":"Phillips WJ, Baghai T, Ong M, Lo B, Ibrahim AM, Smith TKT, et al. A contemporary report of clinical outcomes in patients with melanoma brain metastases. Curr Oncol. 2021;28(1):428\u201339. https:\/\/doi.org\/10.3390\/curroncol28010045.","journal-title":"Curr Oncol"},{"key":"4452_CR11","doi-asserted-by":"publisher","first-page":"e1177","DOI":"10.1016\/j.wneu.2020.11.119","volume":"146","author":"RJ Benveniste","year":"2021","unstructured":"Benveniste RJ, Yechieli R, Diwanji T. Early magnetic resonance imaging after Gamma Knife radiosurgery of brain metastases. World Neurosurg. 2021;146:e1177\u201381. https:\/\/doi.org\/10.1016\/j.wneu.2020.11.119.","journal-title":"World Neurosurg"},{"key":"4452_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.586029","volume":"10","author":"M Khan","year":"2020","unstructured":"Khan M, Zheng T, Zhao Z, Arooj S, Liao G. Efficacy of BRAF inhibitors in combination with stereotactic radiosurgery for the treatment of melanoma brain metastases: a systematic review and meta-analysis. Front Oncol. 2020;10:586029. https:\/\/doi.org\/10.3389\/fonc.2020.586029.","journal-title":"Front Oncol"},{"issue":"1","key":"4452_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-020-03663-w","volume":"152","author":"RE Wegner","year":"2021","unstructured":"Wegner RE, Abel S, D\u2019Amico RS, Mehta GU, Sheehan J. Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome. J Neurooncol. 2021;152(1):79\u201387. https:\/\/doi.org\/10.1007\/s11060-020-03663-w.","journal-title":"J Neurooncol"},{"issue":"12","key":"4452_CR14","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/cncr.33459","volume":"127","author":"ED Bander","year":"2021","unstructured":"Bander ED, Yuan M, Carnevale JA, Reiner AS, Panageas KS, Postow MA, et al. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies. Cancer. 2021;127(12):2062\u201373. https:\/\/doi.org\/10.1002\/cncr.33459.","journal-title":"Cancer"},{"issue":"5","key":"4452_CR15","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.canrad.2021.01.007","volume":"25","author":"C Cabanie","year":"2021","unstructured":"Cabanie C, Biau J, Durando X, Mansard S, Molnar I, Chassin V, et al. Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases. Cancer Radiother. 2021;25(5):432\u201340. https:\/\/doi.org\/10.1016\/j.canrad.2021.01.007.","journal-title":"Cancer Radiother"},{"issue":"3","key":"4452_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3171\/2020.7.JNS192210","volume":"135","author":"WR Kennedy","year":"2021","unstructured":"Kennedy WR, DeWees TA, Acharya S, Mahmood M, Knutson NC, Goddu SM, et al. Internal dose escalation associated with increased local control for melanoma brain metastases treated with stereotactic radiosurgery. J Neurosurg. 2021;135(3):855\u201361. https:\/\/doi.org\/10.3171\/2020.7.JNS192210.","journal-title":"J Neurosurg"},{"issue":"1","key":"4452_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-025-03597-9","volume":"48","author":"JS Reyes","year":"2025","unstructured":"Reyes JS, Lohia VN, Almeida T, Niranjan A, Lunsford LD, Hadjipanayis CG. Artificial intelligence in neurosurgery: a systematic review of applications, model comparisons, and ethical implications. Neurosurg Rev. 2025;48(1):455. https:\/\/doi.org\/10.1007\/s10143-025-03597-9.","journal-title":"Neurosurg Rev"},{"issue":"1","key":"4452_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-026-10394-1","volume":"43","author":"JS Reyes","year":"2026","unstructured":"Reyes JS, Bouras A, Hadjipanayis CG, Lunsford LD, Niranjan A. Gamma knife radiosurgery for cerebellar brain metastases: clinical outcomes and artificial intelligence-based predictive modeling. Clin Exp Metastasis. 2026;43(1):12. https:\/\/doi.org\/10.1007\/s10585-026-10394-1.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"4452_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-026-01645-1","volume":"29","author":"JS Reyes","year":"2026","unstructured":"Reyes JS, Dhol VK, Bouras A, et al. Individualized gamma knife radiosurgery prescription dosing for pituitary adenomas: development and internal validation of a feedforward neural network model. Pituitary. 2026;29(1):42. https:\/\/doi.org\/10.1007\/s11102-026-01645-1.","journal-title":"Pituitary"},{"key":"4452_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1837357","author":"JS Reyes","year":"2026","unstructured":"Reyes JS, Bouras A, Niranjan A, Lunsford LD, Hadjipanayis CG. Clinical GBM hybrid artificial intelligence for prescription dose recommendation and outcome prediction after Gamma Knife radiosurgery treatment: a proof-of-concept. Front Oncol. 2026. https:\/\/doi.org\/10.3389\/fonc.2026.1837357.","journal-title":"Front Oncol"},{"key":"4452_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-026-03983-0","author":"JS Reyes","year":"2026","unstructured":"Reyes JS, Almeida T, Bouras A, Mettenburg J, Niranjan A, Lunsford LD, et al. Radiomics-based artificial intelligence models in brain tumors: a systematic review and meta-analysis of diagnostic performance. Neuroradiology. 2026. https:\/\/doi.org\/10.1007\/s00234-026-03983-0.","journal-title":"Neuroradiology"},{"key":"4452_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-026-03976-z","author":"JS Reyes","year":"2026","unstructured":"Reyes JS, Estupi\u00f1an-Pepinosa DF, Leal-Giraldo SI, Cordoba-Gallego MF, Silva-L\u00f3pez MP, Aguirre-Pati\u00f1o JS, et al. Artificial intelligence and radiomics for pediatric brain tumor classification and molecular characterization: a systematic review. Neuroradiology. 2026. https:\/\/doi.org\/10.1007\/s00234-026-03976-z.","journal-title":"Neuroradiology"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04452-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04452-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04452-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:02:27Z","timestamp":1792803747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04452-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,7]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4452"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04452-z","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,7]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Constantinos Hadjipanayis is a paid consultant for Stryker Corp., Synaptive Medical, and Hemerion Therapeutics. All other authors have no disclosures and declare no competing interests with respect to this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case was conducted under the IRB protocol STUDY20010256. All methods conformed to the Declaration of Helsinki and institutional standards regarding patient privacy and safety.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Waived.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}